PortfoliosLab logoPortfoliosLab logo
ASND vs. CMCL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ASND vs. CMCL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ascendis Pharma A/S (ASND) and Caledonia Mining Corporation Plc (CMCL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ASND achieves a -3.48% return, which is significantly higher than CMCL's -23.85% return.


ASND

1D
-2.20%
1M
-13.76%
YTD
-3.48%
6M
-0.63%
1Y
18.92%
3Y*
30.47%
5Y*
9.47%
10Y*
31.35%

CMCL

1D
-1.30%
1M
-17.18%
YTD
-23.85%
6M
-17.45%
1Y
8.42%
3Y*
16.31%
5Y*
11.37%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ASND vs. CMCL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ASND
Ascendis Pharma A/S
-3.48%54.89%9.31%3.13%-9.22%-19.34%19.88%122.06%56.39%41.96%
CMCL
Caledonia Mining Corporation Plc
-23.85%186.75%-18.90%2.65%11.39%-23.84%93.29%67.37%-26.33%20.43%

Correlation

The correlation between ASND and CMCL is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (All Time)
Calculated using the full available price history since Jun 30, 2017

0.08

Fundamentals

Market Cap

ASND:

$13.28B

CMCL:

$390.18M

EPS

ASND:

$8.08

CMCL:

$3.15

PE Ratio

ASND:

25.47

CMCL:

6.25

PEG Ratio

ASND:

0.12

CMCL:

0.17

PS Ratio

ASND:

14.88

CMCL:

1.42

PB Ratio

ASND:

27.18

CMCL:

1.44

Total Revenue (TTM)

ASND:

$867.51M

CMCL:

$274.16M

Gross Profit (TTM)

ASND:

$764.89M

CMCL:

$142.30M

EBITDA (TTM)

ASND:

-$6.94M

CMCL:

$137.13M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ASND vs. CMCL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASND
ASND Risk / Return Rank: 6060
Overall Rank
ASND Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
ASND Sortino Ratio Rank: 5555
Sortino Ratio Rank
ASND Omega Ratio Rank: 5353
Omega Ratio Rank
ASND Calmar Ratio Rank: 6565
Calmar Ratio Rank
ASND Martin Ratio Rank: 7070
Martin Ratio Rank

CMCL
CMCL Risk / Return Rank: 4646
Overall Rank
CMCL Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
CMCL Sortino Ratio Rank: 4747
Sortino Ratio Rank
CMCL Omega Ratio Rank: 4646
Omega Ratio Rank
CMCL Calmar Ratio Rank: 4747
Calmar Ratio Rank
CMCL Martin Ratio Rank: 4646
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASND vs. CMCL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and Caledonia Mining Corporation Plc (CMCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ASNDCMCLDifference
Sharpe ratioReturn per unit of total volatility

+0.39

Sortino ratioReturn per unit of downside risk

+0.38

Omega ratioGain probability vs. loss probability

1.12

1.08

+0.04

Calmar ratioReturn relative to maximum drawdown

1.09

0.18

+0.91

Martin ratioReturn relative to average drawdown

3.52

0.35

+3.17

ASND vs. CMCL - Sharpe Ratio Comparison

The current ASND Sharpe Ratio is 0.52, which is higher than the CMCL Sharpe Ratio of 0.13. The chart below compares the historical Sharpe Ratios of ASND and CMCL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ASNDCMCLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.52

0.13

+0.39

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.20

0.22

-0.02

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.62

Sharpe Ratio (All Time)

Calculated using the full available price history

0.46

0.33

+0.13

Drawdowns

ASND vs. CMCL - Drawdown Comparison

The maximum ASND drawdown since its inception was -61.72%, smaller than the maximum CMCL drawdown of -65.77%. Use the drawdown chart below to compare losses from any high point for ASND and CMCL.


Loading charts...

Drawdown Indicators


ASNDCMCLDifference

Max Drawdown

Largest peak-to-trough decline

-61.72%

-65.77%

+4.05%

Max Drawdown (1Y)

Largest decline over 1 year

-17.62%

-46.89%

+29.27%

Max Drawdown (3Y)

Largest decline over 3 years

-29.15%

-46.89%

+17.74%

Max Drawdown (5Y)

Largest decline over 5 years

-60.46%

-50.00%

-10.46%

Max Drawdown (10Y)

Largest decline over 10 years

-61.72%

Current Drawdown

Current decline from peak

-17.62%

-46.89%

+29.27%

Average Drawdown

Average peak-to-trough decline

-18.71%

-35.78%

+17.07%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.45%

24.39%

-18.94%

Volatility

ASND vs. CMCL - Volatility Comparison

Ascendis Pharma A/S (ASND) and Caledonia Mining Corporation Plc (CMCL) have volatilities of 14.11% and 13.82%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ASNDCMCLDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.11%

13.82%

+0.29%

Volatility (6M)

Calculated over the trailing 6-month period

29.67%

47.23%

-17.56%

Volatility (1Y)

Calculated over the trailing 1-year period

37.02%

65.15%

-28.13%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.63%

52.69%

-4.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

51.11%

54.58%

-3.47%

Dividends

ASND vs. CMCL - Dividend Comparison

ASND has not paid dividends to shareholders, while CMCL's dividend yield for the trailing twelve months is around 2.84%.


PositionTTM202520242023202220212020201920182017
ASND
Ascendis Pharma A/S
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CMCL
Caledonia Mining Corporation Plc
2.84%2.14%5.95%4.59%4.52%4.29%2.11%3.27%5.23%1.86%

Financials

ASND vs. CMCL - Financials Comparison

This section allows you to compare key financial metrics between Ascendis Pharma A/S and Caledonia Mining Corporation Plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M20222023202420252026
250.66M
66.43M
(ASND) Total Revenue
(CMCL) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ASND and CMCL have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ASND has higher volatility (14.11%) compared to CMCL (13.82%). In terms of maximum drawdown, ASND dropped -61.72% vs CMCL's -65.77%.

ASND currently has the higher Sharpe Ratio (0.52 vs 0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ASND and CMCL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer